💡 Percutaneous cardiac interventions, whether coronary or structural, require antithrombotic therapy to prevent thrombotic events.
Read the 🔑 points on antithrombotic therapy in patients at high bleeding risk: https://t.co/2XBBMtWYEB
#JACCINT#cvCoag@JACCJournals
In-stent restenosis (ISR) is the leading cause of stent failure following percutaneous coronary intervention (PCI), which is estimated to occur in 5-10% of all PCI cases in modern clinical settings. The State-of-the-Art review concentrates on managing ISR, starting with its diagnosis and classification. It then explores the evidence supporting different treatment options for ISR and concludes with a suggested management algorithm derived from the latest scientific data. #EIJBestOf https://t.co/VphOWxT2xV